Status:
UNKNOWN
Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer
Lead Sponsor:
The University of The West Indies
Conditions:
Stage IV Prostate Cancer
Stage IV Colon Cancer
Eligibility:
All Genders
12+ years
Phase:
EARLY_PHASE1
Brief Summary
This study is being done to find the effect of Dibenzyl Trisulphide (active ingredient in Guinea Hen Weed in combination in patients with stage four cancer of the breast, prostate, cervix and colon.
Detailed Description
There have been many claims of the value of Guinea Hen weed in the treatment of different cancers. The preparation is readily available and used locally. The team proposes to validate the studies done...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age: Greater than 12 years.
- Documented histologic evidence of cancer
- Staged as stage IV
- World Health Organization (WHO) Performance Status of between 0 and 2
- Radiological confirmation of metastases with bone scan or X ray, CT and/or MRI scan Exclusion Criteria
- Cancer stages less than stage 4
- Pregnant women
- Children 0 - 12 years
Exclusion
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2020
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT04113096
Start Date
October 1 2018
End Date
September 30 2020
Last Update
October 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medial Sciences
Kingston, Jamaica